Guided Therapeutics (GTHP) Intangibles (2010 - 2011)
Guided Therapeutics (GTHP) posted Intangibles of $409000.0 for Q2 2011, up 36.79% sequentially from $299000.0 in Q4 2010.
Guided Therapeutics (GTHP) Intangibles (2010 - 2011) Analysis & Trends
Guided Therapeutics has reported Intangibles for 2 years, with the latest figure at $409000.0 in Q2 2011.
- Quarterly Intangibles changed N/A year-over-year to $409000.0 in Q2 2011, while the trailing twelve-month figure through Jun 2011 was $409000.0 (changed N/A YoY) and the FY2010 annual result came in at $299000.0, changed N/A from the prior year.
- Intangibles grew to $409000.0 in Q2 2011 per GTHP's latest filing, from $299000.0 in the prior quarter.
- Over five years, Intangibles peaked at $409000.0 in Q2 2011 and troughed at $299000.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.21 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 5.74 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 10.15 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.38 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 101.60 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 1.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 2.98 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.56 Bn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2011 | 409,000.00 |
| Dec 31, 2010 | 299,000.00 |